Peer-influenced content. Sources you trust. No registration required. This is HCN.
JCO Clinical Cancer Informatics (JCO CCI)
The study introduced an ML-based, tunable risk stratification strategy tailored for AML patients treated with venetoclax plus azacitidine. By addressing real-world data limitations and incorporating diverse diagnostic features, the approach enables more accurate and adaptable prognostic modeling than traditional systems, supporting personalized treatment decisions and broader clinical applicability.
Hematology/Oncology March 30th 2026
MDLinx
The method detected 90% of cancer cases, a result very close to the 94% detection rate achieved by colonoscopies and better than all current non-invasive detection methods.
Family Medicine/General Practice October 9th 2025
ReachMD
EchoNext AI achieves diagnostic accuracy surpassing human experts for structural heart disease, demonstrating a new frontier for cardiac disease AI applications.
Cardiology August 26th 2025
Cancer Therapy Advisor
AI-assisted diagnosis of lung cancer showed 87% sensitivity and 87% specificity in a meta-analysis, suggesting potential for improved accuracy in interpreting chest CT scans.
Oncology, Medical October 8th 2024
British Medical Journal (The BMJ)
The TRIPOD+AI guidelines mark a significant update in the standards for reporting prediction models, incorporating advancements in AI to support rigorous, transparent research in healthcare settings, facilitating better clinical decision-making tools.
All Specialties April 22nd 2024
The Dermatologist
In the realm of dermatology, AI and ML are not just futuristic concepts but practical tools enhancing diagnostic precision, patient care, and administrative efficiency. These technologies are reshaping how dermatologists interact with data, patients, and their own continuing education.
Dermatology March 25th 2024